What is VTVT's P/E ratio?

VTV Therapeutics Inc (VTVT) currently trades at a P/E ratio of 5.29.

VTV Therapeutics Inc reports a Return on Equity (ROE) of 2.50%.

What is VTVT's dividend yield?

VTV Therapeutics Inc offers a dividend yield of 0.00%.

What is VTVT's Quality Score?

Our AI rates VTVT's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy VTVT?

Our AI Timing Score for VTVT is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does VTVT belong to?

VTV Therapeutics Inc is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

VTV Therapeutics Inc (VTVT) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-03-31)

VTVT AI Analysis Summary

Our AI summary for VTVT: VTV Therapeutics Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 5.29, ROE of 2.50%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

VTVT

VTV Therapeutics Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 96

USD 32.06

-0.33 (-1.02%) Day Change

Watchlist Portfolio Compare Chart

5.29

P/E

0.10

D/E

2.5%

ROE

2.3%

ROA

0.00%

Div Yield

VTV THERAPEUTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 32.06 Price -0.33 (-1.02%) Day Change	NEWS SCORE: 96

VTVT, the overall quality is not quite good ( Quality = 54) and the timing to buy is ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
Acceleration of ROE growth rate is below our criteria.
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	96
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	32.06
PBV / Sector	1.42 / 44,022.72 GOOD
Earning Per Share	0.57

PE / Sector	5.29 / 19.17 GREAT
PEG or PE/Growth / Sector	N/A / 1.24
Average 1M Daily Value	3.15 M GREAT
Average 1W Daily Value	4.17 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

47%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	6.12 / 98.24
NPM Average (%) / Sector	-56,939.72 / -1,697.63
NPM Change Average (%) / Sector	N/A / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	2.28 / 185,260.96
ROA Average (%) / Sector	-63.48 / 36,684.70
ROA Change Average (%) / Sector	-0.10 / 422,221.66
ROE (%) / Sector	2.50 / 243,762.23
ROE Average (%) / Sector	13.96 / 48,758.47
ROE Change Average (%) / Sector	-129.20 / 424,968.10
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

Registration Details

Analyze Date	2026-08-05 08:01:03
Symbol	VTVT
Name	VTV THERAPEUTICS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	3.94 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	127.57 / 9,586.08

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 3980 Premier Drive, High Point, NC, United States, 27265

Phone: 336 841 0300

Website: https://vtvtherapeutics.com

Sector: Healthcare >> Biotechnology

Description: vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes. The company is also investing a range of molecules across various indications for chronic diseases. It has a license agreement Newsoara Biopharma Co., Ltd. to develop and commercialize phosphodiesterase type 4 inhibitors program. vTv Therapeutics Inc. was incorporated in 2015 and is headquartered in High Point, North Carolina.